Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
20.26
+0.11 (0.55%)
Oct 19, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Pelthos Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $51.71. The average 1-year stock price forecast is 155.23% higher than the current stock price, while the lowest is $40 (+97.43%) and the highest is $64 (+215.89%).
Price Target: $51.71 (+155.23%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Pelthos Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Buy Maintains $50 → $40 | Buy | Maintains | $50 → $40 | +97.43% | Oct 12, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Reiterates $45 | Buy | Reiterates | $45 | +122.11% | Sep 29, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $48 | Buy | Reiterates | $48 | +136.92% | Aug 14, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $66 → $64 | Buy | Reiterates | $66 → $64 | +215.89% | Aug 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $60 | Buy | Reiterates | $60 | +196.15% | Aug 14, 2026 |
Financial Forecast
Revenue This Year
62.87M
from 16.80M
Increased by 274.36%
Revenue Next Year
110.30M
from 62.87M
Increased by 75.43%
EPS This Year
-17.87
from -13.29
EPS Next Year
-5.14
from -17.87
EPS and Forward PE are based on non-GAAP adjusted numbers.